{"nct_id":"NCT02141282","title":"A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy","status":"COMPLETED","status_verified_date":"2022-11","start_date":"2014-09-10","start_date_type":"ACTUAL","primary_completion_date":"2021-12-22","primary_completion_date_type":"ACTUAL","completion_date":"2021-12-22","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}